Impurity Product Detail

Bicalutamide Oxirane Impurity

Chemical Properties and Information

Product Code: CS-T-13775 Impurity
Bicalutamide Oxirane Impurity
API Family
Bicalutamide
Product Code
CS-T-13775

Bicalutamide Oxirane Impurity

Bicalutamide Impurity
Stock Status: In Stock
Live

CAT No.
CS-T-13775
CAS No.
90357-51-0
Molecular Formula
C12H9F3N2O2
Molecular Weight
270.21
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
90357-51-0
Product Code
CS-T-13775
M.F.
C12H9F3N2O2
M.W.
270.21
Smiles
O=C(NC1=CC=C(C#N)C(C(F)(F)F)=C1)C2(C)CO2
Category
Impurity
API Family
Bicalutamide
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
N-[4-cyano-3-(trifluoromethyl)phenyl]-2-methyloxirane-2-carboxamide
References
"Nandu Baban, B,, et al,: Synthetic Communications, 39, 1516 (2009); "
Synonyms
Bicalutamide Impurity 3
Application Notes
"N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide, is an intermediate in synthesis of more complex pharmaceutical compounds. It is used in the synthesis of potential impurities of Bicalutamide , which is an oral nonsteroidal, anti-androgen drug used for prostate cancer."
Purity by HPLC
100.00%
Hazard Compound
Refer MSDS for accurate information.
Overview
"N-[4-Cyano-3-(trifluoromethyl)phenyl]-2-methyl-2-oxiranecarboxamide, is an intermediate in synthesis of more complex pharmaceutical compounds. It is used in the synthesis of potential impurities of Bicalutamide , which is an oral nonsteroidal, anti-androgen drug used for prostate cancer."
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.